Gilead Drug Shows Promising Results In Treating COVID, Ready For Distribution Says CEO

KEY POINTS

  • Gilead’s coronavirus treatment redemsivir was found to reduce recovery time in patients by several days
  • Redemsivir and other drug treatments could serve as stopgap measures until a proper vaccine is ready and approved
  • The Trump administration and Congress re-entered negotiations about a stimulus package to help a U.S. economy hit hard by the pandemic

Final results from Gilead Sciences’ latest remdesivir trial showed the antiviral drug was effective in treating coronavirus patients and cutting recovery time by at least a week.

Gilead’s CEO said, given the positive results, the company was ready for mass production and distribution of the drug.

As of Friday, Johns Hopkins said the U.S. has over 7.6 million confirmed cases of coronavirus and 212,805 reported deaths from it. The latest trial was conducted for nearly a month and involved over 1,062 patients hospitalized for coronavirus. Half of the patients were given remdesivir while the

Read More

Gilead Sciences to sell Europe 500,000 doses of remdesivir

Oct. 8 (UPI) — Gilead Sciences announced Thursday that it’s selling 500,000 doses of remdesivir to European countries as many experience a spike in cases of COVID-19.

The company, which produces the antiviral under the name Veklury, said it reached a deal allowing the European Commission to purchase the drug for 36 countries over the next six months.

Gilead says it ramped up its production of remdesivir in recent months after studies indicated it showed shortened recovery times for some coronavirus patients. The U.S. Food and Drug Administration took control of the distribution of the drug in May after giving it emergency approval for COVID-19 treatment.

Gilead resumed control of distribution earlier this month. The company said it’s on track to produce more than 2 million treatment courses of the drug this year.

“Supply of Veklury is expected to meet global demand by the end of this month, enabling the

Read More

Trump Tests Positive; Gilead Sells Remdesivir Direct; COVID Kills Pain?

Note that some links may require registration or subscription.

President Trump and First Lady Melania Trump announced they both tested positive for COVID-19 and are currently quarantining together. (MedPage Today)

Trump’s announcement on Twitter came just a few hours after one of his closest aides, Hope Hicks, tested positive as well. (Bloomberg)

However, Vice President Mike Pence and his wife Karen tested negative this morning, the VP’s press secretary tweeted.

This comes after 25 states saw a rise in cases in just the past week. (Axios)

As of 8:00 a.m. ET Friday, the unofficial U.S. COVID-19 toll stood at 7,279,065 cases and 207,816 deaths — up 44,808 and 853, respectively, in the past 24 hours.

Things are heating up over in Europe too, as Italy experienced more than 2,000 cases in 24 hours for the first time since the end of April. (

Read More

Gilead Sciences resumes control of remdesivir distribution

Mannequins with face masks and designer clothing fill a window at a Diane Von Furstenberg store in New York City on September 8, 2020. Photo by John Angelillo/UPI | License Photo

A woman wears a face mask while looking at clothing at Diane Von Furstenberg in New York City on September 8. The CFDA announced in June that New York Fashion Week shows will run for only three days in September due to the coronavirus pandemic. Photo by John Angelillo/UPI | License Photo

A girl rides a scooter in Battery Park with a view of the Statue of Liberty in New York City on September 8. Photo by John Angelillo/UPI | License Photo

Visitors wear face masks as they tour the Whitney Museum of American Art as it reopens on September 3 after being closed for over six months. Photo by John Angelillo/UPI | License Photo

Artist Akheneten Komohetep III

Read More